SCHEMBL1608271

SCHEMBL1608271

[c]1nc(C2CCCCO2)cs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9446205 0.95 ALDH1A1 (0.31)
SCHEMBL1606957 0.74 KMO (0.33)
SCHEMBL679900 0.72 KMO (0.36)
SCHEMBL9629937 0.70
SCHEMBL15414960 0.68 MAPK8 (0.33)
SCHEMBL22836855 0.66 MAPK8 (0.31)
SCHEMBL6518361 0.63 HRH3 (0.43)
SCHEMBL21438195 0.63 KCNH2 (0.34)
SCHEMBL10673560 0.63 PIM1 (0.31)
SCHEMBL1607495 0.63 KCNH2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8518975-B2 Gamma secretase modulators Merck Sharp + Dohme Corp. (US) 2013-08-27 US disclosed
US-20110082153-A1 GAMMA SECRETASE MODULATORS SCHERING CORPORATION 2011-04-07 US disclosed
EP-2200990-A1 GAMMA SECRETASE MODULATORS SCHERING CORPORATION (US) 2010-06-30 EP disclosed
WO-2009032277-A1 GAMMA SECRETASE MODULATORS SCHERING CORPORATION (US) 2009-03-12 WO disclosed